1. Cellular reprogramming for understanding and treating human disease
    Riya R. Kanherkar et al, 2014, Front. Cell Dev. Biol. CrossRef
  2. Epigenetics and ADHD
    Meriem Hamza et al, 2017, Journal of Attention Disorders CrossRef
  3. Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis
    XIAOFENG TANG et al, 2016 CrossRef
  4. hBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion
    YOSHITAKA KAMINO et al, 2014 CrossRef
  5. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer
    Yuting Liu et al, 2016, Pharmacological Research CrossRef
  6. Potential adverse effects of engineered nanomaterials commonly used in food on the miRNome
    Jia Pei Lim et al, 2017, Food and Chemical Toxicology CrossRef
  7. Comparative study of dG affinity vs. DNA methylation modulating properties of side chain derivatives of procainamide: insight into its DNA hypomethylating effect
    R. L. Gawade et al, 2016, RSC Adv. CrossRef
  8. Rainbow trout exposed to benzo[a]pyrene yields conserved microRNA binding sites in DNA methyltransferases across 500 million years of evolution
    Christopher Kuc et al, 2017, Sci Rep CrossRef
  9. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer
    Suet-Hui Ow et al, 2017, Exp Biol Med (Maywood) CrossRef
  10. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma
    CHENG-WEI LIN et al, 2014 CrossRef
  11. Benzene exposure is associated with epigenetic changes (Review)
    CONCETTINA FENGA et al, 2016 CrossRef
  12. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells
    Chun-Yi Chuang et al, 2017 CrossRef
  13. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development
    Kevin Dzobo et al, 2018, OMICS: A Journal of Integrative Biology CrossRef
  14. Epigenetic alterations in acute lymphoblastic leukemia
    María del Pilar Navarrete-Meneses et al, 2017, Boletín Médico Del Hospital Infantil de México (English Edition) CrossRef
  15. Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents
    Sk. Abdul Amin et al, 2018, Pharmacological Research CrossRef
  16. DNA methylation as an epigenetic regulator of gallbladder cancer: An overview
    Jibran Sualeh Muhammad et al, 2018, International Journal of Surgery CrossRef
  17. Smyd3-associated regulatory pathways in cancer
    Antonis Giakountis et al, 2017, Seminars in Cancer Biology CrossRef
  18. A Review of Research-Grade Human Induced Pluripotent Stem Cells Qualification and Biobanking Processes
    Aikaterini Ntai et al, 2017, Biopreservation and Biobanking CrossRef
  19. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance
    Rongrong Liao et al, 2018, Mol Biol Rep CrossRef
  20. Hydroxymethylation and Metals: A Potential Epigenetic Marker for Effects of Toxic Exposures
    Lindsey Konkel, 2014, Environmental Health Perspectives CrossRef
  21. Histone Lysine Demethylase Inhibitors
    Ashwini Jambhekar et al, 2017, Cold Spring Harb Perspect Med CrossRef
  22. Tanshinone II A improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model
    Zhang Ying et al, 2018, Journal of Traditional Chinese Medicine CrossRef
  23. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review
    Nilanjan Adhikari et al, 2019, Pharmaceutical Patent Analyst CrossRef
  24. Epigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment “jigsaw puzzle”
    Kevin Dzobo, 2019, OMICS: A Journal of Integrative Biology CrossRef
  25. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes
    Gauri Deb et al, 2019, Mol Carcinog CrossRef
  26. null
    Jonathan W. Boyd et al, 2019 CrossRef
  27. Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors
    Mei Han et al, 2019, Front. Oncol. CrossRef
  28. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy
    Srimanta Patra et al, 2019, Cell. Mol. Life Sci. CrossRef
  29. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer
    Jiahui Xu et al, 2019, Front. Med. CrossRef
  30. null
    James A. Stokes et al, 2016 CrossRef
  31. The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review.
    Xiuping Chen et al, 2014, Med Res Rev CrossRef
  32. null
    Megan Beetch et al, 2019 CrossRef
  33. Efforts towards the synthesis of microsporin B: ready access to both the enantiomers of the key amino acid fragment
    Pandrangi Siva Swaroop et al, 2014, Tetrahedron Letters CrossRef
  34. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases
    Min Shi et al, 2015, Leukemia & Lymphoma CrossRef
  35. Bioactive phytochemicals from shoots and roots of Salvia species
    Amir Reza Jassbi et al, 2016, Phytochem Rev CrossRef
  36. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer
    Keishi Sugimachi et al, 2016, Ann Surg Oncol CrossRef
  37. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
    Jorge Torres-Ferreira et al, 2017, Mol Cancer CrossRef
  38. Epigenetic control of gene expression: Potential implications for cancer treatment.
    F Perri et al, 0 CrossRef
  39. Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning
    Sk. Abdul Amin et al, 2019, Journal of Biomolecular Structure and Dynamics CrossRef
  40. null
    Utkarsh Raj et al, 2017 CrossRef
  41. Alteraciones epigenéticas en leucemia linfoblástica aguda
    María del Pilar Navarrete-Meneses et al, 2017, Boletín Médico del Hospital Infantil de México CrossRef
  42. Junduqing extractive promotes the apoptosis of nasopharyngeal carcinoma cells through down-regulating Mcl-1 and Bcl-xL and up-regulating Caspase-3, Caspase-8 and Caspase-9
    Weiguo Zhao et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  43. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression
    Vasiliki Tzelepi et al, 2019, Pathology CrossRef
  44. Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors
    Suvankar Banerjee et al, 2019, Journal of Biomolecular Structure and Dynamics CrossRef
  45. Genome-wide characterization of 5-hydoxymethylcytosine in melanoma reveals major differences with nevus.
    Catarina Salgado et al, 2020, Genes Chromosomes Cancer CrossRef
  46. Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells
    Danning Shi et al, 2020, BMC Pharmacol Toxicol CrossRef
  47. Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification
    Shan-Ju Yeh et al, 2019, Oncotarget CrossRef
  48. Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents
    Ruirong Ye et al, 2020, Front. Chem. CrossRef
  49. Sodium Tanshinone IIA Sulfonate Attenuates Tumor Oxidative Stress and Promotes Apoptosis in an Intermittent Hypoxia Mouse Model
    Xiao-Bin Zhang et al, 2020, Technol Cancer Res Treat CrossRef
  50. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
    Sanabil Ali Hassan Ahmed et al, 2020, Clin Epigenet CrossRef
  51. Suberoylanilide hydroxamic acid upregulates histone acetylation and activates endoplasmic reticulum stress to induce apoptosis in HepG2 liver cancer cells
    Lei Yu et al, 2019, Oncol Lett CrossRef
  52. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
    Reem Saleh et al, 2020, Front. Immunol. CrossRef
  53. Rho GTPases in cancer radiotherapy and metastasis
    Rui-Jie Zeng et al, 2020, Cancer Metastasis Rev CrossRef
  54. The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis
    Marek Samec et al, 2020, J Cancer Res Clin Oncol CrossRef
  55. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
    Jibran Sualeh Muhammad et al, 2021, Neoplasia CrossRef
  56. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial
    Sadaf Oliai Araghi et al, 2019, Cancer Epidemiol Biomarkers Prev CrossRef
  57. Research Strategies for Nutritional and Physical Activity Epidemiology and Cancer Prevention
    Somdat Mahabir et al, 2018, Cancer Epidemiol Biomarkers Prev CrossRef
  58. Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
    Flavia Zita Francies et al, 2021, Cells CrossRef
  59. Histone Modifying Enzymes in Gynaecological Cancers
    Priya Ramarao-Milne et al, 2021, Cancers CrossRef
  60. null
    Raymond Chang, 2021 CrossRef
  61. Current paradigms in epigenetic anticancer therapeutics and future challenges
    Manoj Singh et al, 2021, Seminars in Cancer Biology CrossRef
  62. In silico study of cancer stage-specific DNA methylation pattern in White breast cancer patients based on TCGA dataset
    Jeremias Ivan et al, 2021, Computational Biology and Chemistry CrossRef
  63. The role of the extracellular matrix protein TGFBI in cancer
    Armando Corona et al, 2021, Cellular Signalling CrossRef
  64. Literature review: enteric nervous system development, genetic and epigenetic regulation in the etiology of Hirschsprung’s disease
    R. Diposarosa et al, 2021, Heliyon CrossRef
  65. null
    Ao Shen et al, 2021 CrossRef
  66. Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers
    David W. Chan et al, 2021, Clin Epigenet CrossRef
  67. null
    Qian Ding et al, 2021 CrossRef
  68. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma
    Oliver J. Pickering et al, 2021, Cancers CrossRef
  69. null
    G.R. Fajardo-Orduña et al, 2021 CrossRef
  70. Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells
    Li-Ling Lin et al, 2015, BMC Genomics CrossRef
  71. Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer
    Luis F. Flores et al, 2021, Cells CrossRef
  72. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms
    Mohammad Tobeiha et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  73. Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates
    Nasreddine El Omari et al, 2021, Nutrients CrossRef
  74. null
    Aruna Pal, 2022 CrossRef
  75. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
    Yuping Wang, 0 CrossRef
  76. Molecular Mechanisms of lncRNAs in the Dependent Regulation of Cancer and Their Potential Therapeutic Use
    Carlos García-Padilla et al, 2022, IJMS CrossRef
  77. Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer
    Deniz Mortazavi et al, 2022, Journal of Oncology CrossRef
  78. null
    Panchami V U et al, 2021 CrossRef
  79. Epigenetic Regulation: A Link between Inflammation and Carcinogenesis
    Bianca Vezzani et al, 2022, Cancers CrossRef
  80. Magnetic Immunosensor Coupled to Enzymatic Signal for Determination of Genomic DNA Methylation
    Yitao Liang et al, 2022, Biosensors CrossRef
  81. Tanshinol suppresses osteosarcoma by specifically inducing apoptosis of U2-OS cells through p53-mediated mechanism
    Shihui Yu et al, 2022, Journal of Ethnopharmacology CrossRef
  82. Understanding Myocardial Metabolism in the Context of Cardio-Oncology
    Jing Liu et al, 2022, Heart Failure Clinics CrossRef
  83. The effects of valproic acid on skin healing: experimental study in rats
    Rachel Biondo-Simões et al, 2022, Acta Cir. Bras. CrossRef
  84. Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.
    Mengguo Liu et al, 2015, Clinics (Sao Paulo) CrossRef
  85. Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
    Rashmi Gupta et al, 2022, Epigenomics CrossRef
  86. NO news: S-(de)nitrosylation of cathepsins and their relationship with cancer
    Camelia Bhattacharyya et al, 2022, Analytical Biochemistry CrossRef
  87. null
    Rashmi Gupta et al, 2022 CrossRef
  88. Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning
    Shada J. Alabed et al, 2022, RSC Adv. CrossRef
  89. Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR : A retrospective study
    Moody Al Roomy et al, 2023, Cytopathology CrossRef
  90. null
    Muthu K. Shanmugam et al, 2023 CrossRef
  91. A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements
    Salam Idriss et al, 2023, Genome Res. CrossRef
  92. DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis.
    Chen Cai et al, 2023, Cell Signal CrossRef
  93. Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression
    Rashmi Srivastava et al, 2023, Epigenomes CrossRef
  94. Vitamin C: From nutrition to oxygen sensing and epigenetics
    Thomas Kietzmann, 2023, Redox Biology CrossRef
  95. WHAT IS EPIGENETIC CHANGE AND WHAT DO WE KNOW ABOUT ITS IMPACT ON MOLECULAR PATHOLOGIC MECHANISMS OF THE DISEASES?
    Kemal Kürşat BOZKURT et al, 2022 CrossRef
  96. SelSA-1, a novel HDAC inhibitor demonstrates enhanced chemotherapeutic potential by redox modulation
    Ayushi Garg et al, 2023, Sci Rep CrossRef
  97. DNA methylation Markers in the Detection of Hepatocellular Carcinoma
    Siyu Fu et al, 2023, European Journal of Cancer CrossRef
  98. miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance
    Reem K. Shahin et al, 2023, Pathology - Research and Practice CrossRef
  99. AF9 sustains glycolysis in colorectal cancer via H3K9ac‐mediated PCK2 and FBP1 transcription
    Xuefeng He et al, 2023, Clinical & Translational Med CrossRef
  100. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL
    Hao Chen et al, 2023, Journal Cellular Physiology CrossRef
  101. Decoding the therapeutic landscape of alpha-linolenic acid: a network pharmacology and bioinformatics investigation against cancer-related epigenetic modifiers
    Amrita Ulhe et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
  102. The epigenetics orchestra of Notch signaling: a symphony for cancer therapy
    Alireza Paniri et al, 2023, Epigenomics CrossRef
  103. Targeting ‘histone mark’: Advanced approaches in epigenetic regulation of telomere dynamics in cancer
    Ankita Das et al, 2024, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  104. DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
    Changling Duan et al, 2024, Heliyon CrossRef
  105. Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses
    Aeshah Alluli et al, 2023, Biochemical Pharmacology CrossRef
  106. Os efeitos do ácido valpróico na cicatrização do plano músculoaponeurótico da parede abdominal: estudo experimental em ratos
    RACHEL BIONDO SIMÕES et al, 2024, Rev. Col. Bras. Cir. CrossRef
  107. Effects of valproic acid on wound healing of the abdominal wall musculoaponeurotic layer: an experimental study in rats
    RACHEL BIONDO SIMÕES et al, 2024, Rev. Col. Bras. Cir. CrossRef
  108. A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors
    Vincenzo Vestuto et al, 2024, J. Med. Chem. CrossRef
  109. Tumor antigen presentation and the associated signal transduction during carcinogenesis
    Sohom Naskar et al, 2024, Pathology - Research and Practice CrossRef
  110. null
    Snehal Nirgude et al, 2024 CrossRef
  111. A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)
    Suvankar Banerjee et al, 2024, Expert Opinion on Therapeutic Patents CrossRef
  112. Change in the serum selenium level of patients with non-metastatic and metastatic non-small cell lung cancer (NSCLC) during radiotherapy as a predictive factor for survival
    Julia Ohlinger et al, 2024, Strahlenther Onkol CrossRef
  113. The role of epigenetics in the diagnosis, treatment and rehabilitation of patients with malignant neoplasms
    A. Yu. Vlasina et al, 2024, jour CrossRef
  114. Exploring the key role of DNA methylation as an epigenetic modulator in oxidative stress related islet cell injury in patients with type 2 diabetes mellitus: a review
    Istiaque Ahmed et al, 2024, J Diabetes Metab Disord CrossRef
  115. Identification of a Novel Biomarker Panel for Breast Cancer Screening
    Maria Vaida et al, 2024, IJMS CrossRef
  116. Defining the genetic profile of prostate cancer
    Ayodeji Folorunsho Ajayi et al, 2024, Urologic Oncology: Seminars and Original Investigations CrossRef